Pharmaron Beijing (03759) reported a net profit attributable to shareholders of RMB1.247 billion for the first three quarters, up 9.31% year on year.
Pharmaron Beijing (03759) announced its results for the first three quarters of 2026. The Group recorded operating revenue of RMB12.003 billion, up 19.01% year on year; net profit attributable to shareholders of the listed company of RMB1.247 billion, up 9.31% year on year; and basic earnings per share of RMB0.6862.
Pharmaron Beijing (03759) announced its results for the first three quarters of 2026. The Group recorded operating revenue of RMB12.003 billion, up 19.01% year on year; net profit attributable to shareholders of the listed company was RMB1.247 billion, up 9.31% year on year; basic earnings per share were RMB0.6862.
Related Articles
Guangdong Dtech Technology (01377) intends to repurchase its A-shares.
Ingenic Semiconductor (03223) reported a net profit attributable to shareholders of approximately RMB2.616 billion for the first three quarters, up 922.95% year on year.
KINDSTAR GLOBAL (09960) repurchased 24,000 shares on October 27 for approximately HK$21,400.
Guangdong Dtech Technology (01377) intends to repurchase its A-shares.
Ingenic Semiconductor (03223) reported a net profit attributable to shareholders of approximately RMB2.616 billion for the first three quarters, up 922.95% year on year.
KINDSTAR GLOBAL (09960) repurchased 24,000 shares on October 27 for approximately HK$21,400.
